GLP-1 Medicaid coverage by state: 2026 tracker

Look up your state

Search all 50 states plus the District of Columbia. “Covered” here means one narrow thing: Medicaid pays for an FDA-approved anti-obesity GLP-1 for adult weight management without requiring a separate qualifying diagnosis. Prior authorization is still required in essentially every covering state.

Source: compiled by Kindr Health from state Medicaid Preferred Drug Lists, prior-authorization forms, and provider bulletins, cross-checked against KFF (January 2026) and Stateline reporting (April 2026). Coverage reflects fee-for-service policy; a managed-care plan’s fine print may differ. Confirm current status with your state Medicaid agency before relying on it.

What each status means

Why the same drug is covered for one diagnosis and denied for another

Federal Medicaid law requires states to cover a drug for its medically accepted indications, but it specifically permits states to exclude “agents when used for anorexia, weight loss, or weight gain” (42 U.S.C. § 1396r-8(d)(2)). That single carve-out — written decades before GLP-1s existed — is the entire reason coverage is a coin flip based on your ZIP code. Diabetes coverage is effectively mandatory. Obesity coverage is optional, and optional benefits are the first thing cut when a state budget tightens.

“Required” coverage is still subject to each state’s prior-authorization and medical-necessity rules. EPSDT requires coverage of medically necessary care for members under 21 even where the adult benefit is excluded.

2026 change log

The national count over time

If your state dropped coverage

Losing a benefit is not the same as losing the treatment. Three pathways usually remain open, and the first one is the most commonly missed: a qualifying diagnosis you already have. Roughly 6 states ended or expired weight-loss coverage in 2026, and in every one of them Medicaid still covers GLP-1s for type 2 diabetes, cardiovascular-risk reduction, obstructive sleep apnea, and noncirrhotic MASH.

• Re-check your diagnosis. Perimenopause and postmenopause drive insulin resistance, rising cardiovascular risk, and worsening sleep apnea. A full metabolic workup often surfaces a covered indication that a weight-only visit never looks for.
• Use EPSDT if the patient is under 21. A blanket adult exclusion cannot be applied to a member under 21 when treatment is medically necessary.
• Appeal. Prior-authorization denials are appealable, and denials issued under criteria that no longer match the state’s current PDL are frequently overturned.
• Plan for cash-pay. Manufacturer direct-pay programs and clinically supervised treatment outside insurance both exist. Compare the real monthly cost before assuming it is out of reach.

Common questions

Sources and methodology

We anchor the national count to KFF, then read the primary state document — Preferred Drug List, prior authorization form, or provider bulletin — for every covering state, every recently changed state, and every high-restriction state. A state is counted only when its own source supports coverage for obesity or weight management. Diabetes-only, cardiovascular, sleep-apnea, MASH, and EPSDT-only pathways are not counted as adult weight-loss coverage. Where we could not reach a primary source, we rely on KFF’s published count and say so.

• KFF — Medicaid Coverage of and Spending on GLP-1s
• KFF — What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid
• Stateline — More states consider dropping GLP-1 weight loss drugs from Medicaid
• 42 U.S.C. § 1396r-8(d)(2) — permitted Medicaid drug exclusions, including agents used for weight loss
• FDA — Wegovy (semaglutide 2.4 mg) Prescribing Information
• FDA — Zepbound (tirzepatide) Prescribing Information

Free to cite with attribution to GLP-1 Medicaid Coverage by State: 2026 Tracker (Kindr Health), last verified July 25, 2026. Journalists and researchers can find our other open datasets in the Kindr Data Hub. Currently tracking 11 covering states.

This page is general health-policy information, not medical or legal advice, and it is not a guarantee of coverage. Coverage decisions rest with your state Medicaid agency and your health plan.